We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESLT icon
3651
Elbit Systems
ESLT
$36.5B
$27K ﹤0.01%
209
+168
+410% +$20.2K
EUM icon
3652
ProShares Trust Short MSCI Emerging Markets
EUM
$9.27M
$27K ﹤0.01%
1,044
-446
-30% -$12.6K
FARM
3653
DELISTED
Farmer Brothers
FARM
$27K ﹤0.01%
5,783
-12,185
-68% -$52.2K
FTEK icon
3654
Fuel Tech
FTEK
$45.3M
$27K ﹤0.01%
+7,001
New +$15.9K
FUNC icon
3655
First United
FUNC
$298M
$27K ﹤0.01%
1,761
-4,699
-73% -$67.6K
GSAT icon
3656
Globalstar
GSAT
$10.7B
$27K ﹤0.01%
5,289
+3,643
+221% +$17.6K
GSG icon
3657
iShares S&P GSCI Commodity-Indexed Trust
GSG
$932M
$27K ﹤0.01%
2,218
+218
+11% +$2.47K
HOFV
3658
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$27K ﹤0.01%
1,000
+903
+931% +$35.4K
INGN icon
3659
Inogen
INGN
$154M
$27K ﹤0.01%
598
-21,207
-97% -$732K
JAGX icon
3660
Jaguar Health
JAGX
$3.85M
0
KAI icon
3661
Kadant
KAI
$3.91B
$27K ﹤0.01%
192
-12,902
-99% -$1.64M
LARK icon
3662
Landmark Bancorp
LARK
$197M
$27K ﹤0.01%
1,520
-3,430
-69% -$61.3K
OLMA icon
3663
Olema Pharmaceuticals
OLMA
$920M
$27K ﹤0.01%
+570
New +$26.7K
PI icon
3664
Impinj
PI
$5.46B
$27K ﹤0.01%
640
-14,890
-96% -$519K
PMVP icon
3665
PMV Pharmaceuticals
PMVP
$65.1M
$27K ﹤0.01%
+439
New +$17.2K
TARA icon
3666
Protara Therapeutics
TARA
$233M
$27K ﹤0.01%
1,122
-706
-39% -$15.2K
TARS icon
3667
Tarsus Pharmaceuticals
TARS
$3.02B
$27K ﹤0.01%
+645
New +$18.4K
SBT
3668
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$27K ﹤0.01%
5,886
-12,659
-68% -$49.1K
GRTS
3669
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$27K ﹤0.01%
6,800
-26,041
-79% -$78.8K
AINC
3670
DELISTED
Ashford Inc.
AINC
$27K ﹤0.01%
3,122
+3,020
+2,961% +$17.8K
ENG
3671
DELISTED
ENGlobal Corp
ENG
$27K ﹤0.01%
+1,042
New +$11.9K
SCPL
3672
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$27K ﹤0.01%
1,949
+1,613
+480% +$23.4K
RTL
3673
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$27K ﹤0.01%
3,713
-61,011
-94% -$429K
SAL
3674
DELISTED
Salisbury Bancorp, Inc.
SAL
$27K ﹤0.01%
1,444
-3,820
-73% -$70.7K
MIC
3675
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$27K ﹤0.01%
732
-15,059
-95% -$463K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.